[
  {
    "ts": null,
    "headline": "CMS to recover ‘uncollected overpayments’ amid Medicare audits",
    "summary": "When announcing a “significant expansion” of its auditing efforts for Medicare Advantage plans, the Centers for Medicare and Medicaid Services said it will collaborate with the Department of Health and Human Services Office of Inspector General to recover uncollected overpayments identified in past audits. Publicly traded companies in the healthcare space include CVS Health (CVS), Centene (CNC), Cigna (CI), Elevance Health (ELV), Humana (HUM), Molina Healthcare (MOH) and UnitedHealth (UNH). Publ",
    "url": "https://finnhub.io/api/news?id=de95d0dfdf10a45cdd629ae6917b9cc3d27795681219c171fe2e05d13509c9bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747947323,
      "headline": "CMS to recover ‘uncollected overpayments’ amid Medicare audits",
      "id": 134658456,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "When announcing a “significant expansion” of its auditing efforts for Medicare Advantage plans, the Centers for Medicare and Medicaid Services said it will collaborate with the Department of Health and Human Services Office of Inspector General to recover uncollected overpayments identified in past audits. Publicly traded companies in the healthcare space include CVS Health (CVS), Centene (CNC), Cigna (CI), Elevance Health (ELV), Humana (HUM), Molina Healthcare (MOH) and UnitedHealth (UNH). Publ",
      "url": "https://finnhub.io/api/news?id=de95d0dfdf10a45cdd629ae6917b9cc3d27795681219c171fe2e05d13509c9bd"
    }
  },
  {
    "ts": null,
    "headline": "Cigna takes different approach with GLP-1s, more favorable for Eli Lilly",
    "summary": "Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly (NYSE:LLY) than rival models.",
    "url": "https://finnhub.io/api/news?id=d67682388ad2176d0f449dcd0d68d9f092205709bca8f8e3f9904916ac8c844f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747937399,
      "headline": "Cigna takes different approach with GLP-1s, more favorable for Eli Lilly",
      "id": 134658390,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly (NYSE:LLY) than rival models.",
      "url": "https://finnhub.io/api/news?id=d67682388ad2176d0f449dcd0d68d9f092205709bca8f8e3f9904916ac8c844f"
    }
  },
  {
    "ts": null,
    "headline": "Cigna is putting a cap on weight loss drug costs",
    "summary": "Getting access to popular weight loss drugs will be simpler and cheaper for some.",
    "url": "https://finnhub.io/api/news?id=7a644298e5d6997af8be16e8463c3b281f4f0a72bf29aed534434914d97e43cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747931400,
      "headline": "Cigna is putting a cap on weight loss drug costs",
      "id": 134658815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Getting access to popular weight loss drugs will be simpler and cheaper for some.",
      "url": "https://finnhub.io/api/news?id=7a644298e5d6997af8be16e8463c3b281f4f0a72bf29aed534434914d97e43cf"
    }
  },
  {
    "ts": null,
    "headline": "Wegovy and Zepbound costs capped at $200 in new Evernorth programme",
    "summary": "The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices in the US.",
    "url": "https://finnhub.io/api/news?id=fa335c2262947c17a39f17722f0057a6115e39dd33709ac359afe7a1b39f5f23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747914991,
      "headline": "Wegovy and Zepbound costs capped at $200 in new Evernorth programme",
      "id": 134648120,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices in the US.",
      "url": "https://finnhub.io/api/news?id=fa335c2262947c17a39f17722f0057a6115e39dd33709ac359afe7a1b39f5f23"
    }
  },
  {
    "ts": null,
    "headline": "Humana, UnitedHealth Stocks Fall. It’s All About a Medicare Crackdown.",
    "summary": "Humana, UnitedHealth Stocks Fall. It’s All About a Medicare Crackdown.",
    "url": "https://finnhub.io/api/news?id=a263496e53e2929cf7b15f073a900dc4c3fdf1172fcf01de4340c405d7e1b1f2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747908720,
      "headline": "Humana, UnitedHealth Stocks Fall. It’s All About a Medicare Crackdown.",
      "id": 134662727,
      "image": "",
      "related": "CI",
      "source": "MarketWatch",
      "summary": "Humana, UnitedHealth Stocks Fall. It’s All About a Medicare Crackdown.",
      "url": "https://finnhub.io/api/news?id=a263496e53e2929cf7b15f073a900dc4c3fdf1172fcf01de4340c405d7e1b1f2"
    }
  }
]